Paper31316876
Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence.
Soni TP and 4 others. Cureus, 2019. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence. Papers, record 31316876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31316876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11836664 | The pathogenesis of mesothelioma. | Semin Oncol | 2002 | https://conductscience.org/library/papers/11836664 | PubMed |
| 2 | 12212604 | Multiple primary malignancies in the head and neck: a clinical review of 121 patients. | Acta Otolaryngol Suppl | 2002 | https://conductscience.org/library/papers/12212604 | PubMed |
| 3 | 12234023 | Therapy-associated solid tumors. | Acta Oncol | 2002 | https://conductscience.org/library/papers/12234023 | PubMed |
| 4 | 12630438 | Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign. | Scand J Work Environ Health | 2003 | https://conductscience.org/library/papers/12630438 | PubMed |
| 5 | 14966099 | Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14966099 | PubMed |
| 6 | 16878323 | Cancer incidence after localized therapy for prostate cancer. | Cancer | 2006 | https://conductscience.org/library/papers/16878323 | PubMed |
| 7 | 18420450 | Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. | Mutat Res | 2008 | https://conductscience.org/library/papers/18420450 | PubMed |
| 8 | 18546265 | Increased risk of colon cancer after external radiation therapy for prostate cancer. | Int J Cancer | 2008 | https://conductscience.org/library/papers/18546265 | PubMed |
| 9 | 21733824 | Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21733824 | PubMed |
| 10 | 22433633 | Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany. | Eur J Cancer Prev | 2012 | https://conductscience.org/library/papers/22433633 | PubMed |
| 11 | 22674346 | Primary cancers before and after prostate cancer diagnosis. | Cancer | 2012 | https://conductscience.org/library/papers/22674346 | PubMed |
| 12 | 25224030 | Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. | Cancer | 2015 | https://conductscience.org/library/papers/25224030 | PubMed |
| 13 | 26139392 | Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. | Carcinogenesis | 2015 | https://conductscience.org/library/papers/26139392 | PubMed |
| 14 | 27260871 | Risk of second primary cancers after malignant mesothelioma and vice versa. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27260871 | PubMed |
| 15 | 2923830 | Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark. | Br J Ind Med | 1989 | https://conductscience.org/library/papers/2923830 | PubMed |
| 16 | 7353405 | Presence of asbestos bodies in organs other than the lung. | Chest | 1980 | https://conductscience.org/library/papers/7353405 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36980631 | Second Primary Cancers in a Population-Based Mesothelioma Registry. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980631 |
Source PubMed
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31316876
GET https://conductscience.org/api/papers/v1/31316876/authors